Dr. Doub is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
725 west lombard street
Baltimore, MD 21201
Summary
- Dr. James Doub, MD is an infectious disease specialist based in Baltimore, MD. He received his medical education at the Marshall University Joan C. Edwards School of Medicine in 2010, followed by a residency in internal medicine at the same institution. He later pursued a fellowship in infectious disease at the University of Maryland from 2014 to 2016. He currently works as a surgical infectious disease specialist at the University of Maryland school of medicine where he conducts NIH funded research in surgical infectious with a subspecialty in bacteriophage therapy.
Education & Training
- University of MarylandFellowship, Infectious Disease, 2014 - 2016
- Marshall University School of MedicineResidency, Internal Medicine, 2010 - 2013
- Marshall University Joan C. Edwards School of MedicineClass of 2010
Certifications & Licensure
- MD State Medical License 2014 - 2026
- VA State Medical License 2013 - 2014
- WV State Medical License 2013 - 2014
Publications & Presentations
PubMed
- Proper duration of antibiotics after video-assisted thoracoscopic surgery for the treatment of thoracic empyema.Ahlam Ashkar, Nina Hazra, Uzoamaka Eke, James B Doub
Infectious Diseases. 2024-11-05 - Clinical Ramifications of Bacterial Aggregation in Pleural Fluid.James B Doub, Nicole Putnam
Infectious Disease Reports. 2024-07-18 - Propensity of Candida spp. prosthetic joint infection clinical isolates to form aggregates in synovial fluid and the clinical ramifications.James B Doub, Hamda Siddiqui
Mycoses. 2024-07-01
Grant Support
- Location of biofilms on infected prosthetic joint infectionsUMBPresent
- Rescue of bacteriophage activity against synovial fluid bacterial aggregatesUMBPresent
- The Role of Teichoic Acid Glycosylation in Phage Activity and Selection in an Ongoing FDA Phase I/II Clinical Study of Bacteriophage Therapy in Chronic Periprosthetic Joint InfectionNIHPresent
- The utility of bacteriophage therapy in fracture-related infections: Preclinical research needed to create effective and reproducible treatment protocolsNIHPresent
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: